Véronique Mainfroid

Véronique Mainfroid is the Head of the Therapeutics Business Line at Kaneka Eurogentec, where they have been advancing their expertise in the field since 2023. Previously, they held key positions, including Global Product Manager for Proteomics at Eurogentec and Senior Scientist in Assay Development at Galapagos Inc. With a strong foundation in protein engineering as a Team Leader at the Université de Liège, Véronique has also contributed to the field as a Senior Scientist at Crucell. Currently, they serve as Deputy President at AnaSpec, where they continue to leverage their extensive experience in the biotechnology industry.